European Archives - Page 1030 of 1043 - European Medical Journal

Continue
EMJ
2 Mins
12 Feb 2014

Cracking the Cancer-Code

The world of medicine and science changed forever the day scientists Watson and Crick discovered the structure of the double helix of DNA, which underpins..
EMJ
2 Mins
12 Feb 2014

Contact Lenses and Acanthamoeba Keratitis

Contact lenses are medical devices and not a makeup tool. According to my 35 years’ experience in Egypt, if the population understands this phrase…
EMJ
12 Feb 2014

Welcome to the new and improved EMJ – Blog!

Now we are all settled into the New Year, we would like to take the opportunity to fill you in with what’s new here at EMJ and what’s install for the rest..
EMJ
12 Feb 2014

IMBRUVICA™ (Ibrutinib) Now Approved in the u.s. For Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

HORSHAM, PA, February 12, 2014 – Janssen Biotech, Inc. [“Janssen”] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™…
EMJ
4 Feb 2014

Cancer Research UK Launches ‘Spaceship’ Smartphone Game to Seek Cancer Cures

Cancer Research UK today unveils Play to Cure: Genes in Space – a world-first mobile phone game in which people across the globe will be able to…
EMJ
30 Dec 2013

Prostatic Inflammation is Determinant for Prostate Overgrowth and Luts Severity in Men with Metabolic Syndrome: Highlights from Two Recently Published Multicentre Studies

Several evidences have pointed out the possible association between Metabolic Syndrome (MetS) and low urinary tract symptoms (LUTS)/benign prostate…
EMJ
30 Dec 2013

Predicting Refractory Detrusor Overactivity: Are There any Clues at Diagnosis

Approximately one-third of patients diagnosed with detrusor overactivity (DO) will be refractory to treatment with antimuscarinic drugs.
EMJ
30 Dec 2013

Practice Patterns for Improving Outcomes in Women with Ileal Neobladder: An Evidence-Based Analysis

The aim of this review is to provide practice pattern on how to obtain best possible oncological and functional outcomes in women with orthotopic…
EMJ
30 Dec 2013

Neuroendocrine Tumour of the Prostate: A Rare Variant

About 95% of prostate cancers are adenocarcinomas. Neuroendocrine differentiation (NED) is seen in virtually all cases of prostatic carcinoma…
EMJ
30 Dec 2013

Multiplex Urinary Tests for Bladder Cancer Diagnosis

The development of accurate and reliable molecular assays that could diagnose bladder cancer would be of significant benefit to both patients and…